Pricing Log in Create free account

Arcus Biosciences, Inc. (RCUS) vs Xencor, Inc. (XNCR)

Arcus Biosciences, Inc. and Xencor, Inc. are both Biotechnology companies. Arcus Biosciences, Inc. and Xencor, Inc. are of similar size ($2.5B and $2.5B). Xencor, Inc. grew revenue faster over the last twelve months: −28.6% against −58.3%. Xencor, Inc. has the higher net margin (−155.6% vs −453.0%) and the lower return on invested capital (−288.7% vs 0.00%). Across the 17 metrics below, Xencor, Inc. leads on 12 and Arcus Biosciences, Inc. on 5.

Valuation

Metric RCUS XNCR Biotechnology median
P/E n/m n/m 10.26
P/S 22.77 24.80 9.18
P/B 6.36 5.17 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 17.49 21.59 8.98
Earnings yield (20.31%) (6.32%) (34.89%)
Free cash flow yield (20.51%) (8.04%) (24.52%)

Profitability

Metric RCUS XNCR Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (475.00%) (205.84%) 0.00%
Net margin (453.00%) (155.59%) 0.00%
Free cash flow margin (465.00%) (198.42%) 0.00%
Return on equity (114.11%) (29.07%) (50.12%)
Return on assets (50.56%) (20.36%) (45.60%)
Return on invested capital 0.00% (288.71%) 0.00%

Growth

Metric RCUS XNCR Biotechnology median
Revenue growth (TTM) (58.33%) (28.56%) 6.26%
EPS growth (last fiscal year) (4.78%) 65.36% 29.88%
Revenue growth, 5-year CAGR 25.93% 0.47% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RCUS XNCR Biotechnology median
Debt to equity 0.28 0.00 0.00
Current ratio 3.34 6.39 4.89
Net debt to EBITDA 2.27 2.51 1.01

Dividend

Metric RCUS XNCR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RCUS XNCR Biotechnology median
Market cap 2.51b 2.53b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack